Ulcerative colitis (uc) Trials in Guangzhou, China
Conditions / Ulcerative colitis (uc) / Guangzhou, China
Clinical trials for Ulcerative colitis (uc) investigate a range of treatment strategies and patient populations.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03006068 | A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03398148 | A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE2/PHASE3 |
| NCT07415044 | LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis | RECRUITING | — |
| NCT02819635 | A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC) | COMPLETED | PHASE2/PHASE3 |
| NCT07442045 | Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis | RECRUITING | — |
| NCT05377580 | A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis | COMPLETED | PHASE2 |
| NCT06922331 | Upadacitinib for Refractory IBD in Asian Children and Elderly: Age-Stratified Analysis | COMPLETED | — |
| NCT06095596 | Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis | RECRUITING | — |
| NCT03653026 | A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT03398135 | A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE3 |